Somatic Comorbidity in Schizophrenia: Some Possible Biological Mechanisms Across the Life Span

Schizophrenia Bulletin

Volumn 42, Issue 6, 2016, Pages 1316-1319

  Dieset, Ingrid ^a,b   Andreassen, Ole A ^a,b   Haukvik, Unn K ^a,c  

^a UNIVERSITY OF OSLO   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c Østfold Hospital Trust   (Norway)

Author keywords

cardiovascular; mortality schizophrenia; schizophrenia; somatic comorbidity

Indexed keywords

AGING; ARTICLE; BRAIN ANALYSIS; CHRONIC DISEASE; COMORBIDITY; HUMAN; NERVE CELL DIFFERENTIATION; PRIORITY JOURNAL; PSYCHOSOMATIC DISORDER; SCHIZOPHRENIA; CARDIOVASCULAR DISEASES; GENETICS;

CARDIOVASCULAR DISEASES; COMORBIDITY; HUMANS; SCHIZOPHRENIA;

EID: 84994444688     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbw028     Document Type: Article

References (32)

1. Olfson M, Gerhard T, Huang C, Crystal S, Stroup TS. Premature mortality among adults with schizophrenia in the United States. JAMA Psychiatry. 2015;72:1-10.
2. Torniainen M, Mittendorfer-Rutz E, Tanskanen A, et al. Antipsychotic treatment and mortality in schizophrenia. Schizophr Bull. 2015;41:656-663.
3. Ryan MC, Collins P, Thakore JH. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry. 2003;160:284-289.
4. Andreassen OA, Djurovic S, Thompson WK, et al. Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors. Am J Hum Genet. 2013;92:197-209.
5. Ripke S, Neale BM, Corvin A, et al. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421-427.
6. Soldatov NM. CACNB2: an emerging pharmacological target for hypertension, heart failure, arrhythmia and mental disorders. Curr Mol Pharmacol. 2015;8:32-42.
7. Tarone G, Balligand JL, Bauersachs J, et al. Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology. Eur J Heart Fail. 2014;16:494-508.
8. Matsuoka R, Abe S, Tokoro F, et al. Association of six genetic variants with myocardial infarction. Int J Mol Med. 2015;35:1451-1459.
9. Molina-Navarro MM, Roselló-Lletí E, Ortega A, et al. Differential gene expression of cardiac ion channels in human dilated cardiomyopathy. PLoS One. 2013;8:e79792.
10. Kim DR, Bale TL, Epperson CN. Prenatal programming of mental illness: current understanding of relationship and mechanisms. Curr Psychiatry Rep. 2015;17:5.
11. O'Neill SM, Curran EA, Dalman C, et al. Birth by caesarean section and the risk of adult psychosis: a population-based cohort study [published online ahead of print November 27, 2015]. Schizophr Bull. doi:10.1093/schbul/sbv152.
12. Fatemi SH, Folsom TD. The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr Bull. 2009;35:528-548.
13. Barker DJ. The origins of the developmental origins theory. J Intern Med. 2007;261:412-417.
14. Langley-Evans SC. Nutritional programming of disease: unravelling the mechanism. J Anat. 2009;215:36-51.
15. Schmidt-Kastner R, van Os J, Esquivel G, Steinbusch HW, Rutten BP. An environmental analysis of genes associated with schizophrenia: hypoxia and vascular factors as interacting elements in the neurodevelopmental model. Mol Psychiatry. 2012;17:1194-1205.
16. Pacheco-López G, Giovanoli S, Langhans W, Meyer U. Priming of metabolic dysfunctions by prenatal immune activation in mice: relevance to schizophrenia. Schizophr Bull. 2013;39:319-329.
17. Correll CU, Robinson DG, Schooler NR, et al. Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study. JAMA Psychiatry. 2014;71:1350-1363.
18. Guest PC, Wang L, Harris LW, et al. Increased levels of circulating insulin-related peptides in first-onset, antipsychotic naïve schizophrenia patients. Mol Psychiatry. 2010;15:118-119.
19. Bradley AJ, Dinan TG. A systematic review of hypothalamicpituitary- adrenal axis function in schizophrenia: implications for mortality. J Psychopharmacol. 2010;24:91-118.
20. Noto C, Ota VK, Santoro ML, et al. Depression, cytokine, and cytokine by treatment interactions modulate gene expression in antipsychotic naive first episode psychosis [published online ahead of print October 22, 2015]. Mol Neurobiol. doi:10.1007/ s12035-015-9489-3.
21. Louveau A, Smirnov I, Keyes TJ, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523:337-341.
22. Réus GZ, Fries GR, Stertz L, et al. The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders. Neuroscience. 2015;300:141-154.
23. Nielsen MØ, Rostrup E, Wulff S, Glenthøj B, Ebdrup BH. Striatal reward activity and antipsychotic-associated weight change in patients with schizophrenia undergoing initial treatment. JAMA Psychiatry. 2016;73:121-128.
24. Baragetti A, Palmen J, Garlaschelli K, et al. Telomere shortening over 6 years is associated with increased subclinical carotid vascular damage and worse cardiovascular prognosis in the general population. J Intern Med. 2015;277:478-487.
25. Koutsouleris N, Davatzikos C, Borgwardt S, et al. Accelerated brain aging in schizophrenia and beyond: a neuroanatomical marker of psychiatric disorders. Schizophr Bull. 2014;40:1140-1153.
26. Dieset I, Haukvik UK, Melle I, et al. Association between altered brain morphology and elevated peripheral endothelial markers-implications for psychotic disorders. Schizophr Res. 2015;161:222-228.
27. Meier MH, Shalev I, Moffitt TE, et al. Microvascular abnormality in schizophrenia as shown by retinal imaging. Am J Psychiatry. 2013;170:1451-1459.
28. Olabi B, Ellison-Wright I, McIntosh AM, Wood SJ, Bullmore E, Lawrie SM. Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies. Biol Psychiatry. 2011;70:88-96.
29. Konradi C, Yang CK, Zimmerman EI, et al. Hippocampal interneurons are abnormal in schizophrenia. Schizophr Res. 2011;131:165-173.
30. Uranova NA, Zimina IS, Vikhreva OV, Krukov NO, Rachmanova VI, Orlovskaya DD. Ultrastructural damage of capillaries in the neocortex in schizophrenia. World J Biol Psychiatry. 2010;11:567-578.
31. Harris LW, Wayland M, Lan M, et al. The cerebral microvasculature in schizophrenia: a laser capture microdissection study. PLoS One. 2008;3:e3964.
32. Mistry M, Gillis J, Pavlidis P. Genome-wide expression profiling of schizophrenia using a large combined cohort. Mol Psychiatry. 2013;18:215-225.